<SEC-DOCUMENT>0001193125-26-303188.txt : 20260714
<SEC-HEADER>0001193125-26-303188.hdr.sgml : 20260714
<ACCEPTANCE-DATETIME>20260714161502
ACCESSION NUMBER:		0001193125-26-303188
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260710
FILED AS OF DATE:		20260714
DATE AS OF CHANGE:		20260714

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Mulay James
		CENTRAL INDEX KEY:			0001684531
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41925
		FILM NUMBER:		261174422

	MAIL ADDRESS:	
		STREET 1:		C/O CG ONCOLOGY, INC.
		STREET 2:		400 SPECTRUM CENTER DRIVE, SUITE 2040
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CG Oncology, Inc.
		CENTRAL INDEX KEY:			0001991792
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				371611499
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		3000 PEGASUS PARK DRIVE
		STREET 2:		SUITE 1640
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75247
		BUSINESS PHONE:		(949) 409-3700

	MAIL ADDRESS:	
		STREET 1:		3000 PEGASUS PARK DRIVE
		STREET 2:		SUITE 1640
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75247
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>4
</DOCUMENT>
</SUBMISSION>